Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Chang

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Plos Pathogens|January 8, 2024
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIPAyana E Morales, Ruby Gumenick, Caitlyn M Genovese, et al.
Systematic Reviews|August 2, 2023
Protocol for the development of guidance for collaborator and partner engagement in health care evidence synthesesPeter Tugwell, Vivian Welch, Olivia Magwood, et al.
Journal of Clinical Epidemiology|April 30, 2013
The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence synthesesReem A Mustafa, Nancy Santesso, Jan Brozek, et al.
Journal of Clinical Epidemiology|February 19, 2025
The GIN-McMaster Guideline Development Checklist extension for engagementJennifer Petkovic, Olivia Magwood, Thomas W Concannon, et al.
Cancer Discovery|October 6, 2025
Correction: Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Cancer Discovery|April 9, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Nature Medicine|October 12, 2021
A quality assessment tool for artificial intelligence-centered diagnostic test accuracy studies: QUADAS-AIViknesh Sounderajah, Hutan Ashrafian, Sherri Rose, et al.
JBI Evidence Synthesis|January 20, 2025
Update to the PRISMA guidelines for network meta-analyses and scoping reviews and development of guidelines for rapid reviews: a scoping review protocolAreti Angeliki Veroniki, Brian Hutton, Adrienne Stevens, et al.
Cancer Discovery|February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint BlockadeXing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Nature|April 8, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Bianca J Lee, Jingjing Jiang, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Plos Pathogens|January 8, 2024
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIPAyana E Morales, Ruby Gumenick, Caitlyn M Genovese, et al.
Systematic Reviews|August 2, 2023
Protocol for the development of guidance for collaborator and partner engagement in health care evidence synthesesPeter Tugwell, Vivian Welch, Olivia Magwood, et al.
Journal of Clinical Epidemiology|April 30, 2013
The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence synthesesReem A Mustafa, Nancy Santesso, Jan Brozek, et al.
Journal of Clinical Epidemiology|February 19, 2025
The GIN-McMaster Guideline Development Checklist extension for engagementJennifer Petkovic, Olivia Magwood, Thomas W Concannon, et al.
Cancer Discovery|October 6, 2025
Correction: Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Cancer Discovery|April 9, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Nature Medicine|October 12, 2021
A quality assessment tool for artificial intelligence-centered diagnostic test accuracy studies: QUADAS-AIViknesh Sounderajah, Hutan Ashrafian, Sherri Rose, et al.
JBI Evidence Synthesis|January 20, 2025
Update to the PRISMA guidelines for network meta-analyses and scoping reviews and development of guidelines for rapid reviews: a scoping review protocolAreti Angeliki Veroniki, Brian Hutton, Adrienne Stevens, et al.
Cancer Discovery|February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint BlockadeXing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Nature|April 8, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Bianca J Lee, Jingjing Jiang, et al.
Pageof 10